Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations

Lisa R. Forbes, Jennifer W. Leiding, Helen C. Su et al.|Journal of Allergy and Clinical Immunology|2018

Cited by 261